In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Lumbar Plexus Injury After MIS Lateral Transpsoas Interbody Fusion at L4/5 Level: A Review of 62 Consecutive Cases

    Final Number:
    137

    Authors:
    Jacob Januszewski DO; Shashank V Gandhi MD; Konrad Bach MD; Andrew C. Vivas MD; Chun Po Yen; Jason Michael Paluzzi; Juan S. Uribe MD

    Study Design:
    Other

    Subject Category:
    Spine

    Meeting: Section on Disorders of the Spine and Peripheral Nerves Spine Summit- 2017

    Introduction: The MIS lateral transpsoas approach (MIS-LIF) has become an increasingly popular means of fusion. Its most frequent complication is lumbar plexus injury. Reported complication rates at the L4-5 disc space vary widely in the literature, bringing into question the safety of MIS-LIF for the L4-5 region. Single level complication rates have been rarely reported alone. We report our experience with lumbar plexus injuries, safety, and efficacy of MIS-LIF at the L4-5 disc space.

    Methods: A retrospective analysis of our MIS-LIF database was performed from 2011-2016. All patients with a standalone or supplemental lateral plate or posterior percutaneous pedicle screw MIS-LIF at the L4/5 level were included. Patients with multilevel fusions were excluded. We analyzed lumbar plexus injuries and the date of resolution.

    Results: Total of 62 patients of 303 met inclusion criteria. Twelve (19%) had an immediate postoperative complication, and almost all were transient and sensory. One had a delayed contralateral sensory and motor (2/5) femoral nerve injury from psoas hematoma. All patient complications except for 2 have completely resolved by the 12-month follow-up resulting in long-term complication rate of 3.2%. The mean LOS and follow-up were 2.1 days and 15 months, respectively. The average ODI improved from 60 to 37 at the last follow-up. The VAS score improved from 7 to 3 at the last follow-up. There were no reoperations secondary to hardware failure or symptomatic pseudarthrosis.

    Conclusions: MIS-transpoas LIF at the L4-L5 disc space is a safe, reproducible, and effective technique with low rate of lumbar plexus injury. When careful surgical technique is applied, patient outcomes may be better than in multilevel MIS-LIF operations above the L4-L5. MIS-LIF at L4/5 also offers lower intraoperative and wound complications than other techniques for this level. Most complications that do occur are transient neuropraxia or mild axonotmesis, which resolve within 6 months.

    Patient Care: By understanding and appreciating the complications possible from a L4-5 transpsoas MIS-LIF, surgeons can make changes in their surgical technique and posteropative care to reduce lumbar plexus injuries and identify symptoms of injury when they do occur. Patients can be counseled appropriately preopeative and posteropatively about the risks of lumbar plexus injury and other complications.

    Learning Objectives: (1) Understand the surgical considerations unique to the L4-5 transpsoas approach due to the lumbar plexus anatomy. (2) Identify the complications possible due to a L4-5 transpoas MIS interbody fusion. (3) Identify advantages of the transpsoas approach to L4-5 compared to anterior or posterior approaches for interbody fusions.

    References: 1. Ahmadian A, Deukmedjian AR, Abel N, Dakwar E, Uribe JS: Analysis of lumbar plexopathies and nerve injury after lateral retroperitoneal transpsoas approach: diagnostic standardization. J Neurosurg Spine 18:289–297, 2013 Available: http://www.ncbi.nlm.nih.gov/pubmed/23259543. 2. Ahmadian A, Verma S, Mundis Jr. GM, Oskouian Jr. RJ, Smith DA, Uribe JS: Minimally invasive lateral retroperitoneal transpsoas interbody fusion for L4-5 spondylolisthesis: clinical outcomes. J Neurosurg Spine 19:314–320, 2013 Available: http://www.ncbi.nlm.nih.gov/pubmed/23889186. 3. Ahmadian A, Bach K, Bolinger B, Malham GM, Okonkwo DO, Kanter AS, et al: Stand-alone minimally invasive lateral lumbar interbody fusion: Multicenter clinical outcomes. J Clin Neurosci 22:740–746, 2015 Available: http://dx.doi.org/10.1016/j.jocn.2014.08.036. 4. Blake Rodgers W, Gerber EJ, Patterson J: Intraoperative and Early Postoperative Complications in Extreme Lateral Interbody Fusion An Analysis of 600 Cases. Spine (Phila Pa 1976) 36:26–33, 2011 5. Cummock MD, Vanni S, Levi AD, Yu Y, Wang MY: An analysis of postoperative thigh symptoms after minimally invasive transpsoas lumbar interbody fusion. J Neurosurg Spine 15:11–18, 2011 Available: http://www.ncbi.nlm.nih.gov/pubmed/21476801. 6. Isaacs RE, Hyde J, Goodrich JA, Rodgers WB, Phillips FM: A prospective, nonrandomized, multicenter evaluation of extreme lateral interbody fusion for the treatment of adult degenerative scoliosis: perioperative outcomes and complications. Spine (Phila Pa 1976) 35:S322--30, 2010 Available: http://www.ncbi.nlm.nih.gov/pubmed/21160396. 7. 1. Moller DJ, Slimack NP, Acosta Jr. FL, Koski TR, Fessler RG, Liu JC: Minimally invasive lateral lumbar interbody fusion and transpsoas approach-related morbidity. Neurosurg Focus 31:E4, 2011 Available: http://www.ncbi.nlm.nih.gov/pubmed/2196186 1. Rodgers WB, Cox CS, Gerber EJ: Early complications of extreme lateral interbody fusion in the obese. J Spinal Disord Tech 23:393–397, 2010 8. Sofianos DA, Brise??o MR, Abrams J, Patel AA: Complications of the lateral transpsoas approach for lumbar interbody arthrodesis: A case series and literature review. Clin Orthop Relat Res 470:1621–1632, 2012

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy